Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter analysis.

MLA

Zaccarelli, Mauro, et al. “Switching to Boosted Protease Inhibitor plus a Second Antiretroviral Drug (Dual Therapy) for Treatment Simplification: A Multicenter Analysis.” Journal of the International AIDS Society, vol. 17, no. 4 Suppl 3, Nov. 2014, p. 19802. EBSCOhost, https://doi.org/10.7448/IAS.17.4.19802.

APA

Zaccarelli, M., Fabbiani, M., Pinnetti, C., Borghi, V., Giannetti, A., Sterrantino, G., Lorenzini, P., Latini, A., Loiacono, L., Colafigli, M., Ammassari, A., D’Ettorre, G., Plazzi, M., Di Giambenedetto, S., & Antinori, A. (2014). Switching to boosted protease inhibitor plus a second antiretroviral drug (dual therapy) for treatment simplification: a multicenter analysis. Journal of the International AIDS Society, 17(4 Suppl 3), 19802. https://doi.org/10.7448/IAS.17.4.19802

Chicago

Zaccarelli, Mauro, Massimiliano Fabbiani, Carmela Pinnetti, Vanni Borghi, Alberto Giannetti, Gaetana Sterrantino, Patrizia Lorenzini, et al. 2014. “Switching to Boosted Protease Inhibitor plus a Second Antiretroviral Drug (Dual Therapy) for Treatment Simplification: A Multicenter Analysis.” Journal of the International AIDS Society 17 (4 Suppl 3): 19802. doi:10.7448/IAS.17.4.19802.